Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Burstein

Showing results (281-290 of 294) with videos related to

Pageof 30
Sort By:
JACC. Advances|June 28, 2024
Cardiopulmonary Exercise Testing in Pediatric Patients With Hypertrophic CardiomyopathyJonathan B Edelson, Helen M Stanley, Jungwon Min, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 5, 2008
Identification and characterization of novel small-molecule protease-activated receptor 2 agonistsLuis R Gardell, Jian-Nong Ma, Jimmi Gerner Seitzberg, et al.
Journal of Medicinal Chemistry|April 3, 2009
Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonistsHanna Pettersson, Anne Bülow, Fredrik Ek, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 21, 2021
Resource utilization in children with paracorporeal continuous-flow ventricular assist devicesDanielle S Burstein, Heather Griffis, Xuemei Zhang, et al.
Psychopharmacology|July 20, 2004
The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapineD M Weiner, H Y Meltzer, I Veinbergs, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2001
5-hydroxytryptamine2A receptor inverse agonists as antipsychoticsD M Weiner, E S Burstein, N Nash, et al.
Journal of the American Heart Association|January 13, 2022
Novel Risk Model to Predict Emergency Department Associated Mortality for Patients Supported With a Ventricular Assist Device: The Emergency Department-Ventricular Assist Device Risk ScoreJonathan B Edelson, Jonathan J Edwards, Hannah Katcoff, et al.
Journal of the American Heart Association|February 5, 2021
An Increasing Burden of Disease: Emergency Department Visits Among Patients With Ventricular Assist Devices From 2010 to 2017Jonathan B Edelson, Jonathan J Edwards, Hannah Katcoff, et al.
ACS Chemical Neuroscience|March 25, 2025
Application of Deuterium in an M<sub>1</sub> Positive Allosteric Modulator Back-Up Program: The Discovery of VU6045422Julie L Engers, Jinming Li, Changho Han, et al.
American Heart Journal|June 5, 2021
Mental health disorders and emergency resource use and outcomes in ventricular assist device supported patientsJonathan J Edwards, Jonathan B Edelson, Hannah Katcoff, et al.
Pageof 30

Showing results (281-290 of 294) with videos related to

Sort By:
Pageof 30
JACC. Advances|June 28, 2024
Cardiopulmonary Exercise Testing in Pediatric Patients With Hypertrophic CardiomyopathyJonathan B Edelson, Helen M Stanley, Jungwon Min, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 5, 2008
Identification and characterization of novel small-molecule protease-activated receptor 2 agonistsLuis R Gardell, Jian-Nong Ma, Jimmi Gerner Seitzberg, et al.
Journal of Medicinal Chemistry|April 3, 2009
Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonistsHanna Pettersson, Anne Bülow, Fredrik Ek, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 21, 2021
Resource utilization in children with paracorporeal continuous-flow ventricular assist devicesDanielle S Burstein, Heather Griffis, Xuemei Zhang, et al.
Psychopharmacology|July 20, 2004
The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapineD M Weiner, H Y Meltzer, I Veinbergs, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2001
5-hydroxytryptamine2A receptor inverse agonists as antipsychoticsD M Weiner, E S Burstein, N Nash, et al.
Journal of the American Heart Association|January 13, 2022
Novel Risk Model to Predict Emergency Department Associated Mortality for Patients Supported With a Ventricular Assist Device: The Emergency Department-Ventricular Assist Device Risk ScoreJonathan B Edelson, Jonathan J Edwards, Hannah Katcoff, et al.
Journal of the American Heart Association|February 5, 2021
An Increasing Burden of Disease: Emergency Department Visits Among Patients With Ventricular Assist Devices From 2010 to 2017Jonathan B Edelson, Jonathan J Edwards, Hannah Katcoff, et al.
ACS Chemical Neuroscience|March 25, 2025
Application of Deuterium in an M<sub>1</sub> Positive Allosteric Modulator Back-Up Program: The Discovery of VU6045422Julie L Engers, Jinming Li, Changho Han, et al.
American Heart Journal|June 5, 2021
Mental health disorders and emergency resource use and outcomes in ventricular assist device supported patientsJonathan J Edwards, Jonathan B Edelson, Hannah Katcoff, et al.
Pageof 30